These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26707143)

  • 1. Curcumin enhances the antitumor effect of ABT-737 via activation of the ROS-ASK1-JNK pathway in hepatocellular carcinoma cells.
    Zheng R; You Z; Jia J; Lin S; Han S; Liu A; Long H; Wang S
    Mol Med Rep; 2016 Feb; 13(2):1570-6. PubMed ID: 26707143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCC cells with high levels of Bcl-2 are resistant to ABT-737 via activation of the ROS-JNK-autophagy pathway.
    Ni Z; Wang B; Dai X; Ding W; Yang T; Li X; Lewin S; Xu L; Lian J; He F
    Free Radic Biol Med; 2014 May; 70():194-203. PubMed ID: 24576507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-cell lymphoma 2 inhibitor ABT-737 induces Beclin1- and reactive oxygen species-dependent autophagy in Adriamycin-resistant human hepatocellular carcinoma cells.
    Yao X; Li X; Zhang D; Xie Y; Sun B; Li H; Sun L; Zhang X
    Tumour Biol; 2017 Mar; 39(3):1010428317695965. PubMed ID: 28351336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib.
    Hikita H; Takehara T; Shimizu S; Kodama T; Shigekawa M; Iwase K; Hosui A; Miyagi T; Tatsumi T; Ishida H; Li W; Kanto T; Hiramatsu N; Hayashi N
    Hepatology; 2010 Oct; 52(4):1310-21. PubMed ID: 20799354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norcantharidin combined with ABT-737 for hepatocellular carcinoma: Therapeutic effects and molecular mechanisms.
    Ren J; Li G; Zhao W; Lin L; Ye T
    World J Gastroenterol; 2016 Apr; 22(15):3962-8. PubMed ID: 27099439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norcantharidin enhances ABT-737-induced apoptosis in hepatocellular carcinoma cells by transcriptional repression of Mcl-1.
    Zhang S; Li G; Ma X; Wang Y; Liu G; Feng L; Zhao Y; Zhang G; Wu Y; Ye X; Qin B; Lu J
    Cell Signal; 2012 Sep; 24(9):1803-9. PubMed ID: 22609455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53-dependent regulation of Mcl-1 contributes to synergistic cell death by ionizing radiation and the Bcl-2/Bcl-XL inhibitor ABT-737.
    Tagscherer KE; Fassl A; Sinkovic T; Combs SE; Roth W
    Apoptosis; 2012 Feb; 17(2):187-99. PubMed ID: 22002102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BH3-only protein expression determines hepatocellular carcinoma response to sorafenib-based treatment.
    Busche S; John K; Wandrer F; Vondran FWR; Lehmann U; Wedemeyer H; Essmann F; Schulze-Osthoff K; Bantel H
    Cell Death Dis; 2021 Jul; 12(8):736. PubMed ID: 34312366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gartanin induces autophagy through JNK activation which extenuates caspase-dependent apoptosis.
    Kim MO; Lee HS; Chin YW; Moon DO; Ahn JS
    Oncol Rep; 2015 Jul; 34(1):139-46. PubMed ID: 25955534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HSP90 inhibitor (NVP-AUY922) enhances the anti-cancer effect of BCL-2 inhibitor (ABT-737) in small cell lung cancer expressing BCL-2.
    Yang H; Lee MH; Park I; Jeon H; Choi J; Seo S; Kim SW; Koh GY; Park KS; Lee DH
    Cancer Lett; 2017 Dec; 411():19-26. PubMed ID: 28987383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Bcl-2 homology domain 3 mimetic ABT-737 targets the apoptotic machinery in acute lymphoblastic leukemia resulting in synergistic in vitro and in vivo interactions with established drugs.
    High LM; Szymanska B; Wilczynska-Kalak U; Barber N; O'Brien R; Khaw SL; Vikstrom IB; Roberts AW; Lock RB
    Mol Pharmacol; 2010 Mar; 77(3):483-94. PubMed ID: 20038611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient elimination of cancer cells by deoxyglucose-ABT-263/737 combination therapy.
    Yamaguchi R; Janssen E; Perkins G; Ellisman M; Kitada S; Reed JC
    PLoS One; 2011; 6(9):e24102. PubMed ID: 21949692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrazinocurcumin and 5-fluorouracil enhance apoptosis and restrain tumorigenicity of HepG2 cells via disrupting the PTEN-mediated PI3K/Akt signaling pathway.
    Zhou Y; Zhang M; Zhang Z; Jia Y; Zhang C; Peng L
    Biomed Pharmacother; 2020 Sep; 129():109851. PubMed ID: 32559627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bcl-2 inhibitor ABT-737 enhances the cisplatin-induced apoptosis in breast cancer T47D cells].
    Chen ZJ; Zhang B; Pan SH; Zhao HM; Zhang Y; Feng WH; Li YY; Cao XC
    Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):891-5. PubMed ID: 22340096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABT-737 potentiates cisplatin-induced apoptosis in human osteosarcoma cells via the mitochondrial apoptotic pathway.
    Zhang F; Yu X; Liu X; Zhou T; Nie T; Cheng M; Liu H; Dai M; Zhang B
    Oncol Rep; 2017 Oct; 38(4):2301-2308. PubMed ID: 28849162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longikaurin A, a natural ent-kaurane, induces G2/M phase arrest via downregulation of Skp2 and apoptosis induction through ROS/JNK/c-Jun pathway in hepatocellular carcinoma cells.
    Liao YJ; Bai HY; Li ZH; Zou J; Chen JW; Zheng F; Zhang JX; Mai SJ; Zeng MS; Sun HD; Pu JX; Xie D
    Cell Death Dis; 2014 Mar; 5(3):e1137. PubMed ID: 24651440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin Sensitizes Hepatocellular Carcinoma Cells to Radiation via Suppression of Radiation-Induced NF-κB Activity.
    Hsu FT; Liu YC; Liu TT; Hwang JJ
    Biomed Res Int; 2015; 2015():363671. PubMed ID: 26539482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABT-737, a Bcl-2 Selective Inhibitor, and Chloroquine Synergistically Kill Renal Cancer Cells.
    Yin P; Jia J; Li J; Song Y; Zhang Y; Chen F
    Oncol Res; 2016; 24(1):65-72. PubMed ID: 27178823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effect of nutlin-3 combined with aspirin in hepatocellular carcinoma HepG2 cells through activation of Bcl-2/Bax signaling pathway.
    Miao R; Xu X; Wang Z; Liu S; Qu K; Chen W; Liu C
    Mol Med Rep; 2018 Mar; 17(3):3735-3743. PubMed ID: 29286113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survivin inhibition is critical for Bcl-2 inhibitor-induced apoptosis in hepatocellular carcinoma cells.
    Zhao X; Ogunwobi OO; Liu C
    PLoS One; 2011; 6(8):e21980. PubMed ID: 21829603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.